Weber Barbara's Form 4 filing
Tango Therapeutics, Inc. (TNGX) · filed Feb 8, 2024
- Accession no.
- 0000950170-24-012999
- Filed
- Feb 8, 2024
- Trade date
- Feb 6-7, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $115.0K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Weber BarbaraCIK 0001800670 | Director, Officer (Chief Executive Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 6, 2024 | Common Stock | SSaleDisposed | −4,681 | $12.56 | −$58,793.36 | 1,539,624 | Direct | |
| Feb 7, 2024 | Common Stock | SSaleDisposed | −4,457 | $12.62 | −$56,247.34 | 1,535,167 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.